Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Basic biology of Bartonella species

David H Spach, MD
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Jennifer Mitty, MD, MPH


Bartonella species are fastidious, gram-negative bacteria that cause a range of manifestations, including cat scratch disease (CSD), bacillary angiomatosis (BA) and other infections in patients with HIV infection, as well as endocarditis. Bartonella has emerged as one of the leading causes of culture-negative endocarditis [1,2]. The organisms proved difficult to isolate and characterize. Analysis of Bartonella 16S ribosomal RNA was instrumental in identifying and classifying this species [3].

The microbiology and pathogenesis of Bartonella infections will be reviewed here. CSD, manifestations in HIV-infected patients, Bartonella endocarditis, and Bartonellosis are discussed separately. (See "Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease" and "Treatment of cat scratch disease" and "Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients" and "Endocarditis caused by Bartonella" and "Clinical features, diagnosis, and treatment of Bartonella quintana infections" and "South American bartonellosis: Oroya fever and verruga peruana".)


Bartonella spp belong to the alpha-2 subgroup of the Proteobacteria based on 16S ribosomal RNA testing and are closely related to the genera Brucella and Agrobacterium. Prior to 1993, the only member of the Bartonella genus that had been identified was Bartonella bacilliformis. In 1993, DNA hybridization data led Brenner and coworkers to propose to unite the genera Bartonella and Rochalimaea, retaining the genus name Bartonella [4]. In 1995, members of the genus Grahamella were merged with the Bartonella genus, but Grahamella spp are not known to cause human disease.

The three most important Bartonella spp known to cause human disease are B. bacilliformis, Bartonella quintana, and Bartonella henselae; other Bartonella spp reported to have caused disease in humans, but whose role is less well defined, are Bartonella elizabethae [5], Bartonella vinsonii [6,7], Bartonella clarridgeiae [8], Bartonella grahamii [9], Bartonella koehlerae [10], Bartonella alsatica [11], and Bartonella rochalimae [12]. Infection with B. elizabethae may be more common than previously appreciated. As an example, investigators performed Bartonella serologic testing on samples collected in 1997 and 1998 from 204 injection drug users in New York City and found 46 percent had positive serologic reactions to B. elizabethae [13]. In addition, one group of investigators used 16S RNA gene sequencing to identify a new serogroup of B. henselae, termed serogroup "Marseille" [14].

Although analysis of 16S ribosomal DNA sequences have characteristically been used to differentiate Bartonella spp, investigators have determined that nucleotide base sequence data for a 940-bp fragment of the citrate synthase-encoding gene (gltA) appears more useful than the 16S ribosomal DNA sequence data for investigating the evolutionary relationships of Bartonella spp [15]. Phylogenetic studies have determined that the highly virulent pathogen, B. bacilliformis, is the sole representative of an ancestral lineage, and other Bartonella species that cause human disease have evolved in a separate lineage; the evolution of the newer species has correlated with their adaptation to distinct mammalian reservoirs [16,17].


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Mar 16, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Raoult D, Fournier PE, Drancourt M, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 1996; 125:646.
  2. Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent "culture-negative" endocarditis. Clin Infect Dis 1995; 20:1044.
  3. Spach DH, Koehler JE. Bartonella-associated infections. Infect Dis Clin North Am 1998; 12:137.
  4. Brenner DJ, O'Connor SP, Winkler HH, Steigerwalt AG. Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. Int J Syst Bacteriol 1993; 43:777.
  5. Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872.
  6. Roux V, Eykyn SJ, Wyllie S, Raoult D. Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human. J Clin Microbiol 2000; 38:1698.
  7. Welch DF, Carroll KC, Hofmeister EK, et al. Isolation of a new subspecies, Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice. J Clin Microbiol 1999; 37:2598.
  8. Margileth AM, Baehren DF. Chest-wall abscess due to cat-scratch disease (CSD) in an adult with antibodies to Bartonella clarridgeiae: case report and review of the thoracopulmonary manifestations of CSD. Clin Infect Dis 1998; 27:353.
  9. Kerkhoff FT, Bergmans AM, van Der Zee A, Rothova A. Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis. J Clin Microbiol 1999; 37:4034.
  10. Avidor B, Graidy M, Efrat G, et al. Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol 2004; 42:3462.
  11. Raoult D, Roblot F, Rolain JM, et al. First isolation of Bartonella alsatica from a valve of a patient with endocarditis. J Clin Microbiol 2006; 44:278.
  12. Eremeeva ME, Gerns HL, Lydy SL, et al. Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 2007; 356:2381.
  13. Comer JA, Diaz T, Vlahov D, et al. Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. Am J Trop Med Hyg 2001; 65:855.
  14. Drancourt M, Birtles R, Chaumentin G, et al. New serotype of Bartonella henselae in endocarditis and cat-scratch disease. Lancet 1996; 347:441.
  15. Birtles RJ, Raoult D. Comparison of partial citrate synthase gene (gltA) sequences for phylogenetic analysis of Bartonella species. Int J Syst Bacteriol 1996; 46:891.
  16. Dehio C. Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction. Cell Microbiol 2008; 10:1591.
  17. Saenz HL, Engel P, Stoeckli MC, et al. Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors. Nat Genet 2007; 39:1469.
  18. Welch DF, Hensel DM, Pickett DA, et al. Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory. J Clin Microbiol 1993; 31:2381.
  19. Larson AM, Dougherty MJ, Nowowiejski DJ, et al. Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol 1994; 32:1492.
  20. Wong MT, Thornton DC, Kennedy RC, Dolan MJ. A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol 1995; 33:742.
  21. Maggi RG, Duncan AW, Breitschwerdt EB. Novel chemically modified liquid medium that will support the growth of seven bartonella species. J Clin Microbiol 2005; 43:2651.
  22. Koehler JE, Quinn FD, Berger TG, et al. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 327:1625.
  23. Breitschwerdt EB, Kordick DL. Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev 2000; 13:428.
  24. Koehler JE, Glaser CA, Tappero JW. Rochalimaea henselae infection. A new zoonosis with the domestic cat as reservoir. JAMA 1994; 271:531.
  25. Chomel BB, Abbott RC, Kasten RW, et al. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol 1995; 33:2445.
  26. Kordick DL, Wilson KH, Sexton DJ, et al. Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. J Clin Microbiol 1995; 33:3245.
  27. Chang CC, Chomel BB, Kasten RW, et al. Molecular epidemiology of Bartonella henselae infection in human immunodeficiency virus-infected patients and their cat contacts, using pulsed-field gel electrophoresis and genotyping. J Infect Dis 2002; 186:1733.
  28. Kordick DL, Brown TT, Shin K, Breitschwerdt EB. Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats. J Clin Microbiol 1999; 37:1536.
  29. O'Reilly KL, Bauer RW, Freeland RL, et al. Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16). Infect Immun 1999; 67:3066.
  30. Heller R, Artois M, Xemar V, et al. Prevalence of Bartonella henselae and Bartonella clarridgeiae in stray cats. J Clin Microbiol 1997; 35:1327.
  31. Droz S, Chi B, Horn E, et al. Bartonella koehlerae sp. nov., isolated from cats. J Clin Microbiol 1999; 37:1117.
  32. Foucault C, Barrau K, Brouqui P, Raoult D. Bartonella quintana Bacteremia among Homeless People. Clin Infect Dis 2002; 35:684.
  33. Rolain JM, Brouqui P, Koehler JE, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48:1921.
  34. Greub G, Raoult D. Bartonella: new explanations for old diseases. J Med Microbiol 2002; 51:915.
  35. Ellis BA, Regnery RL, Beati L, et al. Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis 1999; 180:220.
  36. Birtles RJ, Canales J, Ventosilla P, et al. Survey of Bartonella species infecting intradomicillary animals in the Huayllacallán Valley, Ancash, Peru, a region endemic for human bartonellosis. Am J Trop Med Hyg 1999; 60:799.
  37. Breitschwerdt EB, Hegarty BC, Hancock SI. Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii. J Clin Microbiol 1998; 36:2645.
  38. Chomel BB, Kasten RW, Floyd-Hawkins K, et al. Experimental transmission of Bartonella henselae by the cat flea. J Clin Microbiol 1996; 34:1952.
  39. Bonilla DL, Kabeya H, Henn J, et al. Bartonella quintana in body lice and head lice from homeless persons, San Francisco, California, USA. Emerg Infect Dis 2009; 15:912.
  40. Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis 2006; 12:217.
  41. Telford SR 3rd, Wormser GP. Bartonella spp. transmission by ticks not established. Emerg Infect Dis 2010; 16:379.
  42. Reis C, Cote M, Le Rhun D, et al. Vector competence of the tick Ixodes ricinus for transmission of Bartonella birtlesii. PLoS Negl Trop Dis 2011; 5:e1186.
  43. Minnick MF, Battisti JM. Pestilence, persistence and pathogenicity: infection strategies of Bartonella. Future Microbiol 2009; 4:743.
  44. Ben-Tekaya H, Gorvel JP, Dehio C. Bartonella and Brucella--weapons and strategies for stealth attack. Cold Spring Harb Perspect Med 2013; 3.
  45. Harms A, Dehio C. Intruders below the radar: molecular pathogenesis of Bartonella spp. Clin Microbiol Rev 2012; 25:42.
  46. Schülein R, Seubert A, Gille C, et al. Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella. J Exp Med 2001; 193:1077.
  47. Minnick MF, Mitchell SJ, McAllister SJ. Cell entry and the pathogenesis of Bartonella infections. Trends Microbiol 1996; 4:343.
  48. Mernaugh G, Ihler GM. Deformation factor: an extracellular protein synthesized by Bartonella bacilliformis that deforms erythrocyte membranes. Infect Immun 1992; 60:937.
  49. Eicher SC, Dehio C. Bartonella entry mechanisms into mammalian host cells. Cell Microbiol 2012; 14:1166.
  50. Rolain JM, Arnoux D, Parzy D, et al. Experimental infection of human erythrocytes from alcoholic patients with Bartonella quintana. Ann N Y Acad Sci 2003; 990:605.
  51. Riess T, Andersson SG, Lupas A, et al. Bartonella adhesin a mediates a proangiogenic host cell response. J Exp Med 2004; 200:1267.
  52. Brouqui P, Raoult D. Bartonella quintana invades and multiplies within endothelial cells in vitro and in vivo and forms intracellular blebs. Res Microbiol 1996; 147:719.
  53. Dehio C, Meyer M, Berger J, et al. Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. J Cell Sci 1997; 110 ( Pt 18):2141.
  54. Kempf VA, Lebiedziejewski M, Alitalo K, et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 2005; 111:1054.
  55. Kempf VA, Volkmann B, Schaller M, et al. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol 2001; 3:623.
  56. Kirby JE. In vitro model of Bartonella henselae-induced angiogenesis. Infect Immun 2004; 72:7315.
  57. Dehio C. Recent progress in understanding Bartonella-induced vascular proliferation. Curr Opin Microbiol 2003; 6:61.
  58. Resto-Ruiz S, Burgess A, Anderson BE. The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol 2003; 22:431.
  59. Arvand M, Ignatius R, Regnath T, et al. Bartonella henselae-specific cell-mediated immune responses display a predominantly Th1 phenotype in experimentally infected C57BL/6 mice. Infect Immun 2001; 69:6427.
  60. Musso T, Badolato R, Ravarino D, et al. Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response. Infect Immun 2001; 69:5974.
  61. Capo C, Amirayan-Chevillard N, Brouqui P, et al. Bartonella quintana bacteremia and overproduction of interleukin-10: model of bacterial persistence in homeless people. J Infect Dis 2003; 187:837.
  62. Popa C, Abdollahi-Roodsaz S, Joosten LA, et al. Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect Immun 2007; 75:4831.